# A Study of Vorinostat in Patients With Solid Tumors (MK-0683-029)

> **NCT00127127** · PHASE1 · COMPLETED · sponsor: **Merck Sharp & Dohme LLC** · enrollment: 18 (actual)

## Conditions studied

- Tumors

## Interventions

- **DRUG:** vorinostat

## Key facts

- **NCT ID:** NCT00127127
- **Lead sponsor:** Merck Sharp & Dohme LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-06-10
- **Primary completion:** 2009-08-21
- **Final completion:** 2009-08-21
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2022-09-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00127127

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00127127, "A Study of Vorinostat in Patients With Solid Tumors (MK-0683-029)". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00127127. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*